18,259 results on '"alopecia areata"'
Search Results
2. Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
3. European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
4. Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
5. Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study
6. Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
7. A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (BRAVE-AA1)
8. A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS)
9. A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA)
10. A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
11. Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia
12. To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia
13. Dupilumab in the Treatment of Pediatric Alopecia Areata (PEDAL)
14. Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
15. Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females
16. Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men
17. Treatment of Androgenetic Alopecia in Men for 24 Weeks (MINOX)
18. 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
19. A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata (BRAVE-AA2)
20. Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata (SIGNAL-AA)
21. Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA) (CCCA)
22. A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants
23. A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA) (SOT01)
24. Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
25. Sham LaserCap vs. LaserCap SD vs. LaserCap HD+
26. Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata
27. Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia
28. A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia
29. DPCP for the Treatment of Alopecia Areata
30. At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
31. Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser
32. Hydraderm for Androgenic Alopecia
33. Platelet Rich Plasma for Frontal Fibrosing Alopecia
34. Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias
35. Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss (CAPELLI)
36. Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men
37. A Study to Evaluate the Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
38. A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects
39. CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
40. A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
41. A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)
42. Phase III Study of KX-826 With Adult Male Patients With AGA
43. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study
44. Improving Disease Severity
45. Use of Botulinum Toxin in the Treatment of Androgenic Alopecia
46. Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata
47. Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia
48. Autologous Stromal Vascular Fraction in Treatment of Male Androgenic Alopecia
49. Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases (DEVISE)
50. A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo (Derma-001)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.